AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...

AstraZeneca said on Monday its experimental precision drug developed with Daiichi Sankyo did not significantly improve ...

The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...

A recent survey from AARP found that roughly 40 percent of adults age 65-plus who are eligible for Medicare have either ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...

Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the ...

The uptick in AstraZeneca share price came after the company announced that it has received permission to import for sale and ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

Learn how Oracle Cloud Infrastructure and its cutting-edge AI features are bringing new benefits to cancer care by helping ...

Nearly 200 chemicals connected to breast cancer are used in the making of food packaging and plastic tableware, and dozens of ...

A new AstraZeneca drug has failed to extend significantly the lives of breast cancer patients in a blow to the company’s ...